STOCK TITAN

[144] Voyager Therapeutics, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Voyager Therapeutics (VYGR) filed a Form 144 notice for a proposed sale of 5,843 common shares. The shares carry an aggregate market value of $27,936.55 and are slated for sale through Fidelity Brokerage Services LLC on or about 10/03/2025 on the NASDAQ.

The securities were acquired on 10/01/2025 via restricted stock vesting from the issuer as compensation. This is a routine compliance notice that permits the holder to sell these shares under Rule 144, subject to applicable volume and manner-of-sale conditions.

Voyager Therapeutics (VYGR) ha presentato un modulo 144 per una proposta di vendita di 5.843 azioni ordinarie. Le azioni hanno un valore di mercato complessivo di $27.936,55 e sono destinate alla vendita tramite Fidelity Brokerage Services LLC in data indicativa 10/03/2025 sul NASDAQ.

I titoli sono stati acquisiti il 1 ottobre 2025 tramite vesting di azioni vincolate dall'emittente come compenso. Si tratta di una consueta comunicazione di conformità che autorizza il detentore a vendere queste azioni ai sensi della Regola 144, soggetta alle condizioni di volume e di modalità di vendita applicabili.

Voyager Therapeutics (VYGR) presentó un aviso Form 144 para una posible venta de 5.843 acciones ordinarias. Las acciones tienen un valor de mercado agregado de $27.936,55 y se prevé que se vendan a través de Fidelity Brokerage Services LLC alrededor del 03/10/2025 en NASDAQ.

Los valores se adquirieron el 01/10/2025 mediante vesting de acciones restringidas por parte del emisor como compensación. Este es un aviso de cumplimiento de rutina que permite al titular vender estas acciones conforme a la Regla 144, sujeto a las condiciones de volumen y de forma de venta aplicables.

Voyager Therapeutics (VYGR)는 제안된 매각을 위한 Form 144 통지를 제출했습니다. 5,843 주의 보통주를 매각하려 하며, 이 주식은 $27,936.55의 총 시가를 가지며 Fidelity Brokerage Services LLC를 통해 NASDAQ에서 2025년 10월 3일경에 매각될 예정입니다.

해당 증권은 발행사로부터 제한 주식 양도를 통해 보상으로 2025년 10월 1일에 취득되었습니다. 이는 해당 주식을 규칙 144에 따라 매도할 수 있도록 허용하는 일상적인 준수 통지로, 관련 거래량 및 매도 방식 요건에 따라 적용됩니다.

Voyager Therapeutics (VYGR) a déposé un avis Form 144 en vue d'une vente proposée de 5 843 actions ordinaires. Les actions affichent une valeur marchande brute de 27 936,55 $ et devraient être vendues par l'intermédiaire de Fidelity Brokerage Services LLC vers le 03/10/2025 sur le NASDAQ.

Les titres ont été acquis le 01/10/2025 par vesting d’actions restreintes de l’émetteur en tant que rémunération. Il s’agit d’un avis de conformité de routine qui permet au détenteur de vendre ces actions conformément à la Règle 144, sous réserve des conditions de volume et de modalité de vente applicables.

Voyager Therapeutics (VYGR) hat eine Form 144-Mitteilung für einen geplanten Verkauf von 5.843 Stammaktien eingereicht. Die Aktien haben einen gesamten Marktwert von 27.936,55 $ und sollen voraussichtlich über Fidelity Brokerage Services LLC am oder um 03.10.2025 an der NASDAQ verkauft werden.

Die Wertpapiere wurden am 01.10.2025 durch Restricted Stock Vesting vom Emittenten als Vergütung erworben. Dies ist ein routinemäßiger Compliance-Hinweis, der dem Inhaber erlaubt, diese Anteile gemäß Regel 144 zu verkaufen, unter Vorbehalt der geltenden Volumen- und Verkaufsmodalitäten.

Voyager Therapeutics (VYGR) قد قدمت إشعار Form 144 للبيع المقترح لـ 5,843 أسهم عادية. الأسـهم تحمل قيمة سوقية إجمالية قدرها 27,936.55 دولار ومن المقرر بيعها من خلال Fidelity Brokerage Services LLC في أو نحو 03/10/2025 في NASDAQ.

تم اكتساب الأوراق المالية في 01/10/2025 عبر إتاحة الأسهم المقيدة من المصدر كـ تعويض. هذا هو إشعار امتثال روتيني يسمح لحاملها ببيع هذه الأسهم وفقاً للق Rule 144، مع الالتزام بشروط الحجم ونمط البيع المعمول بها.

Voyager Therapeutics (VYGR) 已提交 Form 144 通知,拟出售 5,843 股普通股。这些股票的 总市值为 $27,936.55,计划通过 Fidelity Brokerage Services LLC2025/10/03 在 NASDAQ 交易出售。

这些证券于 2025/10/01 通过公司发行人作为 补偿受限股票归属 获得。这是一个常规合规通知,允许持有人依照 Rule 144 出售这些股票,须符合相关的成交量和出售方式条件。

Positive
  • None.
Negative
  • None.

Voyager Therapeutics (VYGR) ha presentato un modulo 144 per una proposta di vendita di 5.843 azioni ordinarie. Le azioni hanno un valore di mercato complessivo di $27.936,55 e sono destinate alla vendita tramite Fidelity Brokerage Services LLC in data indicativa 10/03/2025 sul NASDAQ.

I titoli sono stati acquisiti il 1 ottobre 2025 tramite vesting di azioni vincolate dall'emittente come compenso. Si tratta di una consueta comunicazione di conformità che autorizza il detentore a vendere queste azioni ai sensi della Regola 144, soggetta alle condizioni di volume e di modalità di vendita applicabili.

Voyager Therapeutics (VYGR) presentó un aviso Form 144 para una posible venta de 5.843 acciones ordinarias. Las acciones tienen un valor de mercado agregado de $27.936,55 y se prevé que se vendan a través de Fidelity Brokerage Services LLC alrededor del 03/10/2025 en NASDAQ.

Los valores se adquirieron el 01/10/2025 mediante vesting de acciones restringidas por parte del emisor como compensación. Este es un aviso de cumplimiento de rutina que permite al titular vender estas acciones conforme a la Regla 144, sujeto a las condiciones de volumen y de forma de venta aplicables.

Voyager Therapeutics (VYGR)는 제안된 매각을 위한 Form 144 통지를 제출했습니다. 5,843 주의 보통주를 매각하려 하며, 이 주식은 $27,936.55의 총 시가를 가지며 Fidelity Brokerage Services LLC를 통해 NASDAQ에서 2025년 10월 3일경에 매각될 예정입니다.

해당 증권은 발행사로부터 제한 주식 양도를 통해 보상으로 2025년 10월 1일에 취득되었습니다. 이는 해당 주식을 규칙 144에 따라 매도할 수 있도록 허용하는 일상적인 준수 통지로, 관련 거래량 및 매도 방식 요건에 따라 적용됩니다.

Voyager Therapeutics (VYGR) a déposé un avis Form 144 en vue d'une vente proposée de 5 843 actions ordinaires. Les actions affichent une valeur marchande brute de 27 936,55 $ et devraient être vendues par l'intermédiaire de Fidelity Brokerage Services LLC vers le 03/10/2025 sur le NASDAQ.

Les titres ont été acquis le 01/10/2025 par vesting d’actions restreintes de l’émetteur en tant que rémunération. Il s’agit d’un avis de conformité de routine qui permet au détenteur de vendre ces actions conformément à la Règle 144, sous réserve des conditions de volume et de modalité de vente applicables.

Voyager Therapeutics (VYGR) hat eine Form 144-Mitteilung für einen geplanten Verkauf von 5.843 Stammaktien eingereicht. Die Aktien haben einen gesamten Marktwert von 27.936,55 $ und sollen voraussichtlich über Fidelity Brokerage Services LLC am oder um 03.10.2025 an der NASDAQ verkauft werden.

Die Wertpapiere wurden am 01.10.2025 durch Restricted Stock Vesting vom Emittenten als Vergütung erworben. Dies ist ein routinemäßiger Compliance-Hinweis, der dem Inhaber erlaubt, diese Anteile gemäß Regel 144 zu verkaufen, unter Vorbehalt der geltenden Volumen- und Verkaufsmodalitäten.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did VYGR disclose in this Form 144?

A proposed sale of 5,843 common shares with an aggregate market value of $27,936.55 through Fidelity Brokerage Services LLC.

When is the approximate sale date for the VYGR shares?

The notice lists an approximate sale date of 10/03/2025 on the NASDAQ.

How were the VYGR shares to be sold acquired?

They were acquired on 10/01/2025 via restricted stock vesting from the issuer as compensation.

How many VYGR shares are involved and what is the stated value?

The filing covers 5,843 shares with an aggregate market value of $27,936.55.

Which broker is handling the proposed VYGR share sale?

The broker named is Fidelity Brokerage Services LLC.

On which exchange are the VYGR shares planned to be sold?

The filing lists NASDAQ as the exchange.
Voyager Therapeutics Inc

NASDAQ:VYGR

VYGR Rankings

VYGR Latest News

VYGR Latest SEC Filings

VYGR Stock Data

277.34M
46.37M
16.52%
59.95%
5.31%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
LEXINGTON